A key feature of the was the introduction of several new drug monographs for emerging therapies, such as Bendamustine Hydrochloride and Mesna. This edition also served as a critical phase in the transition toward a fully electronic publishing model , emphasizing a single source of official compendial content.
: The 2018 edition integrated updates from the Pharmacopeial Discussion Group (PDG) , which works to align standards across global pharmacopeias to facilitate international trade and regulatory consistency. U.S. Pharmacopeia National Formulary 2018: USP ...
: Standards in USP 41–NF 36 became official on May 1, 2018 , following their release on November 1, 2017, to allow manufacturers time to align their testing methods. A key feature of the was the introduction
: USP continued updating general chapters to modernize organic impurities testing , ensuring that drug product monographs reflect current analytical capabilities. : Standards in USP 41–NF 36 became official
: New standards were established for several medications, including Bendamustine Hydrochloride for Injection and Ipratropium Bromide and Albuterol Sulfate Inhalation Solution .
: The edition utilized over 3,500 Reference Standards to verify the identity, strength, and purity of medicines, helping manufacturers maintain compliance with USP-NF quality benchmarks .